These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 7249797

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. In vitro antibacterial activity and beta-lactamase stability of cefodizime, a new cephalosporin antibiotic.
    Kasai K, Tsuji A, Miyazaki S, Goto S, Fujimoto K, Masuyoshi S, Arai S.
    Jpn J Antibiot; 1984 Jul; 37(7):1294-305. PubMed ID: 6092739
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Computerized analysis of activity profiles of beta-lactams].
    Pitton JS, Philippin JL, Fournier P.
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):581-5. PubMed ID: 3937131
    [Abstract] [Full Text] [Related]

  • 47. [In vitro activity of ceftriaxone on hospital bacteria. Results of a multicenter study].
    Soussy CJ, Deforges L, Le Van Thoi J, Chanal M, Sirot D, Acar JF, Kitzis MD, Thabaut A, Meyran M, Dabernat H.
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):469-72. PubMed ID: 2868442
    [Abstract] [Full Text] [Related]

  • 48. Antibacterial activity in vitro and regression studies for ceftazidime and ceftriaxone.
    Frimodt-Møller N, Højbjerg T, Hvass E, Møller S, Mortensen I, Thomsen VF.
    Acta Pathol Microbiol Immunol Scand B; 1985 Jun; 93(3):181-8. PubMed ID: 3929558
    [Abstract] [Full Text] [Related]

  • 49. Comparative in vitro activity of ceftriaxone against clinical bacterial isolates in Nigeria.
    Obaseiki-Ebor EE, Afonya TC, Oyaide SM.
    Chemotherapy; 1985 Jun; 31(2):130-7. PubMed ID: 3872779
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Cefpirome (HR 810). A new broad spectrum cephalosporin].
    Bryskier A, Chantot JF.
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):477-81. PubMed ID: 3937123
    [Abstract] [Full Text] [Related]

  • 52. In vitro susceptibility of Haemophilus influenzae and neisseria gonorrhoeae to Ro 13-9904 in comparison with other beta-lactam antibiotics.
    Ng WS, Chau PY, Arnold K.
    Antimicrob Agents Chemother; 1981 May; 19(5):925-6. PubMed ID: 6271052
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Richards DM, Heel RC, Brogden RN, Speight TM, Avery GS.
    Drugs; 1984 Jun; 27(6):469-527. PubMed ID: 6329638
    [Abstract] [Full Text] [Related]

  • 55. Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolates.
    Jones RN, Fuchs PC, Barry AL, Ayers LW, Gerlach EH, Gavan TL.
    Diagn Microbiol Infect Dis; 1987 Mar; 6(3):193-8. PubMed ID: 3568594
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. In vitro of cefotaxime against cephalothin-resistant clinical isolates.
    Van Landuyt HW, Pyckavet M.
    Antimicrob Agents Chemother; 1979 Jul; 16(1):109-11. PubMed ID: 475369
    [Abstract] [Full Text] [Related]

  • 60. Cefotoxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro.
    Hamilton-Miller JM, Brumfitt W, Reynolds AV.
    J Antimicrob Chemother; 1978 Sep; 4(5):437-44. PubMed ID: 308505
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.